logo-loader

VentriPoint Diagnostics closes C$500,000 first tranche of financing

Last updated: 19:07 05 Sep 2018 BST, First published: 14:07 05 Sep 2018 BST

1536170984_canadian_dollar
The firm has now issued to one investor, over 2.38mln units at C$0.21 each, it said

Heart-imaging specialist VentriPoint Diagnostics Ltd (CVE:VPT) has closed the first tranche of its non-brokered private placing, raising C$500,000.

On August 15, the group said it was set for a C$1mln  placing to be used for sales and marketing, development and general working capital. The firm has now issued to one investor, over 2.38mln units at C$0.21 each. Each unit consists of one Ventripoint share, and one-half of a share warrant. Each whole warrant will entitle the bearer to buy one further share at US$0.34 each for two years after the issue.

Ventripoint said that the total size of the placing was up to C$1mln. The company intends to close the second tranche of the private placement in the near future.

'We have a shot at being a multi-billion dollar company', says VentriPoint...

Dr George Adams, CEO & president of VentriPoint Diagnostics (CVE:VPT) runs Proactive through the company's heart analysis technology and growth strategy as well as plans for 2017.

on 20/3/17